{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:17:55Z","timestamp":1792019875349,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-511x-13-59","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T01:02:11Z","timestamp":1396314131000},"source":"Crossref","is-referenced-by-count":13,"title":["Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris"],"prefix":"10.1186","volume":"13","author":[{"given":"Tsuyoshi","family":"Nozue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nozato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichi","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyasu","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Michishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"JC LaRosa","year":"2005","unstructured":"LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, : Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005, 352: 1425-1435. 10.1056\/NEJMoa050461","journal-title":"N Engl J Med"},{"key":"1056_CR2","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2010.02.026","volume":"55","author":"SJ Nicholls","year":"2010","unstructured":"Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM, Nissen SE: Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol. 2010, 55: 2399-2407. 10.1016\/j.jacc.2010.02.026","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","volume":"103","author":"M Aikawa","year":"2001","unstructured":"Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P: An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001, 103: 276-283. 10.1161\/01.CIR.103.2.276","journal-title":"Circulation"},{"key":"1056_CR4","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/01.CIR.0000035654.18341.5E","volume":"106","author":"A Nair","year":"2002","unstructured":"Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG: Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002, 106: 2200-2206. 10.1161\/01.CIR.0000035654.18341.5E","journal-title":"Circulation"},{"key":"1056_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","volume":"104","author":"P Libby","year":"2001","unstructured":"Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001, 104: 365-372. 10.1161\/01.CIR.104.3.365","journal-title":"Circulation"},{"key":"1056_CR6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jacc.2007.06.051","volume":"50","author":"R Kawaguchi","year":"2007","unstructured":"Kawaguchi R, Oshima S, Jingu M, Tsurugaya H, Toyama T, Hoshizaki H, Taniguchi K: Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007, 50: 1641-1646. 10.1016\/j.jacc.2007.06.051","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ahj.2011.11.004","volume":"163","author":"T Nozue","year":"2012","unstructured":"Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Sozu T, Terashima M, Michishita I: Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis. Am Heart J. 2012, 163: 191-199. 10.1016\/j.ahj.2011.11.004","journal-title":"Am Heart J"},{"key":"1056_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jcin.2009.04.016","volume":"2","author":"K Nasu","year":"2009","unstructured":"Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, Kinoshita Y, Matsubara T, Matsuo H, Asakura K, Asakura Y, Terashima M, Takayama T, Honye J, Hirayama A, Saito S, Suzuki T: Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. JACC Cardiovasc Interv. 2009, 2: 689-696.","journal-title":"JACC Cardiovasc Interv"},{"key":"1056_CR9","first-page":"522","volume":"24","author":"P Eshtehardi","year":"2012","unstructured":"Eshtehardi P, McDaniel MC, Dhawan SS, Binongo JN, Krishnan SK, Golub L, Corban MT, Raggi P, Quyyumi AA, Samady H: Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function. J Invasive Cardiol. 2012, 24: 522-529.","journal-title":"J Invasive Cardiol"},{"key":"1056_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jcin.2009.03.015","volume":"2","author":"MK Hong","year":"2009","unstructured":"Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ: Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. JACC Cardiovasc Interv. 2009, 2: 679-688. 10.1016\/j.jcin.2009.03.015","journal-title":"JACC Cardiovasc Interv"},{"key":"1056_CR11","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"GS Mintz","year":"2001","unstructured":"Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG: American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of Intravascular Ultrasound Studies (IVUS). a report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2001, 37: 1478-1492. 10.1016\/S0735-1097(01)01175-5","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0009-9120(00)00065-5","volume":"33","author":"H Kohno","year":"2000","unstructured":"Kohno H, Sueshige N, Oguri K, Izumidate H, Masunari T, Kawamura M, Itabe H, Takano T, Hasegawa A, Nagai R: Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody. Clin Biochem. 2000, 33: 243-253. 10.1016\/S0009-9120(00)00065-5","journal-title":"Clin Biochem"},{"key":"1056_CR13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-2275(20)42055-3","volume":"32","author":"D Pfaffinger","year":"1991","unstructured":"Pfaffinger D, Schuelke J, Kim C, Fless GM, Scanu AM: Relationship between apo[a] isoforms and Lp[a] density in subjects with different apo[a] phenotype: a study before and after a fatty meal. J Lipid Res. 1991, 32: 679-683.","journal-title":"J Lipid Res"},{"key":"1056_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0009-8981(97)06524-8","volume":"261","author":"A Gaw","year":"1997","unstructured":"Gaw A, Gourlay CW, Brown EA, Bell MA: Evaluation of a new automated latex agglutination assay for lipoprotein(a): comparison with a manual ELISA. Clin Chim Acta. 1997, 261: 175-183. 10.1016\/S0009-8981(97)06524-8","journal-title":"Clin Chim Acta"},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1373\/clinchem.2010.149559","volume":"57","author":"Y Ito","year":"2011","unstructured":"Ito Y, Fujimura M, Ohta M, Hirano T: Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem. 2011, 57: 57-65. 10.1373\/clinchem.2010.149559","journal-title":"Clin Chem"},{"key":"1056_CR16","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa001066","volume":"349","author":"AA Ariyo","year":"2003","unstructured":"Ariyo AA, Thach C, Tracy R, : Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med. 2003, 349: 2108-2115. 10.1056\/NEJMoa001066","journal-title":"N Engl J Med"},{"key":"1056_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","volume":"102","author":"J Danesh","year":"2000","unstructured":"Danesh J, Collins R, Peto R: Lipoprotein(a) and coronary heart disease Meta-analysis of prospective studies. Circulation. 2000, 102: 1082-1085. 10.1161\/01.CIR.102.10.1082","journal-title":"Circulation"},{"key":"1056_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/clc.4960270503","volume":"27","author":"A Deb","year":"2004","unstructured":"Deb A, Caplice NM: Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. Clin Cardiol. 2004, 27: 258-264. 10.1002\/clc.4960270503","journal-title":"Clin Cardiol"},{"key":"1056_CR19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/ATVBAHA.112.251306","volume":"32","author":"JD Spence","year":"2012","unstructured":"Spence JD, Koschinsky M: Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both?. Arterioscler Thromb Vasc Biol. 2012, 32: 1550-1551. 10.1161\/ATVBAHA.112.251306","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1056_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jacc.2012.01.078","volume":"60","author":"A Helgadottir","year":"2012","unstructured":"Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T, Jones GT, van Rij AM, Eapen DJ, Baas AF, Tregouet DA, Morange PE, Emmerich J, Lindblad B, Gotts\u00e4ter A, Kiemeny LA, Lindholt JS, Sakalihasan N, Ferrell RE, Carey DJ, Elmore JR, Tsao PS, Grarup N, J\u00f8rgensen T, Witte DR, Hansen T, Pedersen O, Pola R, Gaetani E, Magnadottir HB: Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol. 2012, 60: 722-729. 10.1016\/j.jacc.2012.01.078","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR21","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/01.CIR.91.4.948","volume":"91","author":"W Terres","year":"1995","unstructured":"Terres W, Tatsis E, Pfalzer B, Beil FU, Beisiegel U, Hamm CW: Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation. 1995, 91: 948-950. 10.1161\/01.CIR.91.4.948","journal-title":"Circulation"},{"key":"1056_CR22","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1194\/jlr.M008961","volume":"51","author":"SJ Nicholls","year":"2010","unstructured":"Nicholls SJ, Tang WH, Scoffone H, Brennan DM, Hartiala J, Allayee H, Hazen SL: Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. J Lipid Res. 2010, 51: 3055-3061. 10.1194\/jlr.M008961","journal-title":"J Lipid Res"},{"key":"1056_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jacc.2006.03.047","volume":"48","author":"M Hartmann","year":"2006","unstructured":"Hartmann M, von Birgelen C, Mintz GS, Stoel MG, Eggebrecht H, Wieneke H, Fahy M, Neumann T, van der Palen J, Louwerenburg HW, Verhorst PM, Erbel R: Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol. 2006, 48: 446-452. 10.1016\/j.jacc.2006.03.047","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR24","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, Bor\u00e9n J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokg\u00f6zoglu L, Tybj\u00e6rg-Hansen A, : Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010, 31: 2844-2853. 10.1093\/eurheartj\/ehq386","journal-title":"Eur Heart J"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1161\/ATVBAHA.113.302479","volume":"33","author":"PJ Nestel","year":"2013","unstructured":"Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR: Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease. Arterioscler Thromb Vasc Biol. 2013, 33: 2902-2908. 10.1161\/ATVBAHA.113.302479","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1056_CR26","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.ijcard.2012.05.007","volume":"167","author":"SW Kwon","year":"2013","unstructured":"Kwon SW, Lee BK, Hong BK, Kim JY, Choi EY, Sung JM, Rhee JH, Park YM, Ma DW, Chung H, Mun HS, Lee SJ, Park JK, Min PK, Yoon YW, Rim SJ, Kwon HM: Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients. Int J Cariol. 2013, 167: 1990-1994. 10.1016\/j.ijcard.2012.05.007.","journal-title":"Int J Cariol"},{"key":"1056_CR27","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jacc.2012.04.038","volume":"60","author":"S Tsimikas","year":"2012","unstructured":"Tsimikas S, Hall JL: Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. J Am Coll Cardiol. 2012, 60: 716-721. 10.1016\/j.jacc.2012.04.038","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/01.ATV.18.4.641","volume":"18","author":"LB Nielsen","year":"1998","unstructured":"Nielsen LB, Juul K, Nordestgaard BG: Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation. Arterioscler Thromb Vasc Biol. 1998, 18: 641-649. 10.1161\/01.ATV.18.4.641","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1056_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00041433-199508000-00007","volume":"6","author":"VM Maher","year":"1995","unstructured":"Maher VM, Brown BG: Lipoprotein (a) and coronary heart disease. Curr Opin Lipidol. 1995, 6: 229-235. 10.1097\/00041433-199508000-00007","journal-title":"Curr Opin Lipidol"},{"key":"1056_CR30","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","volume":"27","author":"S Kiechl","year":"2007","unstructured":"Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F, Wiedermann CJ, Oberthaler S, Xu Q, Witztum JL, Tsimikas S: Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arterioscler Thromb Vasc Biol. 2007, 27: 1788-1795. 10.1161\/ATVBAHA.107.145805","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1056_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa043175","volume":"353","author":"S Tsimikas","year":"2005","unstructured":"Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB: Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005, 353: 46-57. 10.1056\/NEJMoa043175","journal-title":"N Engl J Med"},{"key":"1056_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","volume":"12","author":"TA Seimon","year":"2010","unstructured":"Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, Tabas I: Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. 2010, 12: 467-482. 10.1016\/j.cmet.2010.09.010","journal-title":"Cell Metab"},{"key":"1056_CR33","first-page":"113","volume":"3","author":"A Nair","year":"2007","unstructured":"Nair A, Margolis MP, Kuban BD, Vince DG: Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention. 2007, 3: 113-120.","journal-title":"EuroIntervention"},{"key":"1056_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.amjcard.2012.12.008","volume":"111","author":"T Nozue","year":"2013","unstructured":"Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I, : Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study). Am J Cardiol. 2013, 111: 923-929. 10.1016\/j.amjcard.2012.12.008","journal-title":"Am J Cardiol"},{"key":"1056_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1002358","volume":"364","author":"GW Stone","year":"2011","unstructured":"Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW, : A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011, 364: 226-235. 10.1056\/NEJMoa1002358","journal-title":"N Engl J Med"},{"key":"1056_CR36","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","volume":"47","author":"R Virmani","year":"2006","unstructured":"Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006, 47: C13-C18. 10.1016\/j.jacc.2005.10.065","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR37","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/01.CIR.80.5.1313","volume":"80","author":"GM Kostner","year":"1989","unstructured":"Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL: HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 1989, 80: 1313-1319. 10.1161\/01.CIR.80.5.1313","journal-title":"Circulation"},{"key":"1056_CR38","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.1995.03530220037029","volume":"274","author":"VM Maher","year":"1995","unstructured":"Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ: Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA. 1995, 274: 1771-1774. 10.1001\/jama.1995.03530220037029","journal-title":"JAMA"},{"key":"1056_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.atherosclerosis.2006.11.037","volume":"192","author":"JM McKenney","year":"2007","unstructured":"McKenney JM, Jones PH, Bays HE, Knopp RH, Kashyap ML, Ruoff GE, McGovern ME: Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis. 2007, 192: 432-437. 10.1016\/j.atherosclerosis.2006.11.037","journal-title":"Atherosclerosis"},{"key":"1056_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2362.1989.tb00223.x","volume":"19","author":"VW Armstrong","year":"1989","unstructured":"Armstrong VW, Schleef J, Thiery J, Muche R, Schuff-Werner P, Eisenhauer T, Seidel D: Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels. Eur J Clin Invest. 1989, 19: 235-240. 10.1111\/j.1365-2362.1989.tb00223.x","journal-title":"Eur J Clin Invest"},{"key":"1056_CR41","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","volume":"361","author":"AJ Taylor","year":"2009","unstructured":"Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M: Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med. 2009, 361: 2113-2122. 10.1056\/NEJMoa0907569","journal-title":"N Engl J Med"},{"key":"1056_CR42","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","volume":"365","author":"WE Boden","year":"2011","unstructured":"Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W, : Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011, 365: 2255-2267.","journal-title":"N Engl J Med"},{"key":"1056_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","volume":"41","author":"S Tsimikas","year":"2003","unstructured":"Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL: Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol. 2003, 41: 360-370.","journal-title":"J Am Coll Cardiol"},{"key":"1056_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0021-9150(93)90040-2","volume":"103","author":"AD MBewu","year":"1993","unstructured":"MBewu AD, Durrington PN, Bulleid S, Mackness MI: The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein. Atherosclerosis. 1993, 103: 65-71. 10.1016\/0021-9150(93)90040-2","journal-title":"Atherosclerosis"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-13-59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:21:09Z","timestamp":1648732869000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-13-59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-13-59","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]},"article-number":"59"}}